Patents by Inventor Evros Vassiliou

Evros Vassiliou has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITION FOR THE TREATMENT OF TYPE I ALLERGIC HYPERSENSITIVITIES BY IMMUNE DESENSITIZATION THROUGH SLIT IMMUNOTHERAPY WITH UNADULTERATED ALLERGEN, VITAMIN A, VITAMIN D AND AN IMMUNO-EFFECTIVE AMOUNT OF ADJUVANT OF ESSENTIAL OILS
    Publication number: 20210023206
    Abstract: In one embodiment, the invention provides a composition that includes therapeutically effective amount of any unadulterated pollen listed in FIG. 1. The invention is comprised of specific mass(es) of the unadulterated pollen composition of one or multiple pollens per daily dose, a range of mass of vitamin A, a range of mass of vitamin D, and an immune-effective amount of an adjuvant comprised of one or more of the essential oils Eucalyptol, Thymus, Oregano, Bergamot, Fennel, Tea Tree, Peppermint, Fennel, Cinnamon and Clove. The duration of the therapeutically effective amount of unadulterated pollen will preferably be administered 0-52 weeks prior to exposure to the allergen and for a period of 6-8 weeks. It could also be administered as a maintenance treatment during the allergic exposure and for multiple years. In some embodiments, the invention provides a method for treating allergies.
    Type: Application
    Filed: October 5, 2020
    Publication date: January 28, 2021
    Inventor: EVROS VASSILIOU
  • METHOD, COMPOSITION & APPARATUS FOR THE TREATMENT OF TYPE I ALLERGIC HYPERSENSITIVITIES BY IMMUNE DESENSITIZATION THROUGH SLIT IMMUNOTHERAPY WITH UNADULTERATED ALLERGEN, VITAMIN A AND VITAMIN D
    Publication number: 20180360951
    Abstract: In one embodiment, the invention provides a composition that includes therapeutically effective amount of any unadulterated pollen listed in FIG. 1. The invention is comprised of specific mass(es) of the unadulterated pollen composition of one or multiple pollens per daily dose, a range of mass of vitamin A, a range of mass of vitamin D, and a suspension buffer facilitating absorption of the therapeutic composition. The duration of the therapeutically effective amount of unadulterated pollen will preferably be administered 0-52 weeks prior to exposure to the allergen and for a period of 6-8 weeks. It could also be administered as a maintenance treatment during the allergic exposure and for multiple years. In some embodiments, the invention provides a method for treating allergies including administering an effective amount of a composition comprised of unadulterated pollen, vitamin A, vitamin D and a suspension buffer as shown in FIG. 1.
    Type: Application
    Filed: February 28, 2018
    Publication date: December 20, 2018
    Inventor: EVROS VASSILIOU
  • NOVEL FATTY ACID-SALICYLATE CONJUGATES WITH ENHANCED THERAPEUTIC PROPERTIES
    Publication number: 20150374839
    Abstract: The invention provides compositions and methods for treating or preventing cancer with an inventive composition. The invention relates to the fields of biomedicine, pharmacology, and molecular biology.
    Type: Application
    Filed: April 22, 2015
    Publication date: December 31, 2015
    Applicant: KEAN UNIVERSITY
    Inventors: Evros Vassiliou, James Robert Merrill
  • Fatty acid-salicylate conjugates with enhanced therapeutic properties
    Patent number: 9056139
    Abstract: The invention provides compositions and methods for treating or preventing cancer with an inventive composition. The invention relates to the fields of biomedicine, pharmacology, and molecular biology.
    Type: Grant
    Filed: June 28, 2013
    Date of Patent: June 16, 2015
    Assignee: KEAN UNIVERSITY
    Inventor: Evros Vassiliou
  • NOVEL FATTY ACID-SALICYLATE CONJUGATES WITH ENHANCED THERAPEUTIC PROPERTIES
    Publication number: 20140011776
    Abstract: The invention provides compositions and methods for treating or preventing cancer with an inventive composition. The invention relates to the fields of biomedicine, pharmacology, and molecular biology.
    Type: Application
    Filed: June 28, 2013
    Publication date: January 9, 2014
    Applicant: KEAN UNIVERSITY
    Inventors: Evros Vassiliou, James Robert Merritt